The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer

OBJECTIVE: To study differences in baseline characteristics and outcomes of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving first-line docetaxel-containing chemotherapy on prospective clinical studies (trial participants) versus those receiving this therapy outside of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Goyal, Jatinder, Nuhn, Philipp, Huang, Peng, Tyagi, Prachi, Oh, Daniel, Carducci, Michael A., Eisenberger, Mario A., Antonarakis, Emmanuel S.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715077/
https://ncbi.nlm.nih.gov/pubmed/22702837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2012.11286.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires